DNA Polymerase Fidelity and the Polymerase Chain Reaction Kristin A
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Mutation in DNA Polymerase Α Rescues WEE1KO Sensitivity to HU
International Journal of Molecular Sciences Article A Mutation in DNA Polymerase α Rescues WEE1KO Sensitivity to HU Thomas Eekhout 1,2 , José Antonio Pedroza-Garcia 1,2 , Pooneh Kalhorzadeh 1,2, Geert De Jaeger 1,2 and Lieven De Veylder 1,2,* 1 Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Gent, Belgium; [email protected] (T.E.); [email protected] (J.A.P.-G.); [email protected] (P.K.); [email protected] (G.D.J.) 2 Center for Plant Systems Biology, VIB, 9052 Gent, Belgium * Correspondence: [email protected] Abstract: During DNA replication, the WEE1 kinase is responsible for safeguarding genomic integrity by phosphorylating and thus inhibiting cyclin-dependent kinases (CDKs), which are the driving force of the cell cycle. Consequentially, wee1 mutant plants fail to respond properly to problems arising during DNA replication and are hypersensitive to replication stress. Here, we report the identification of the pola-2 mutant, mutated in the catalytic subunit of DNA polymerase α, as a suppressor mutant of wee1. The mutated protein appears to be less stable, causing a loss of interaction with its subunits and resulting in a prolonged S-phase. Keywords: replication stress; DNA damage; cell cycle checkpoint Citation: Eekhout, T.; Pedroza- 1. Introduction Garcia, J.A.; Kalhorzadeh, P.; De Jaeger, G.; De Veylder, L. A Mutation DNA replication is a highly complex process that ensures the chromosomes are in DNA Polymerase α Rescues correctly replicated to be passed onto the daughter cells during mitosis. Replication starts WEE1KO Sensitivity to HU. Int. -
Expression of Telomerase Activity, Human Telomerase RNA, and Telomerase Reverse Transcriptase in Gastric Adenocarcinomas Jinyoung Yoo, M.D., Ph.D., Sonya Y
Expression of Telomerase Activity, Human Telomerase RNA, and Telomerase Reverse Transcriptase in Gastric Adenocarcinomas Jinyoung Yoo, M.D., Ph.D., Sonya Y. Park, Seok Jin Kang, M.D., Ph.D., Byung Kee Kim, M.D., Ph.D., Sang In Shim, M.D., Ph.D., Chang Suk Kang, M.D., Ph.D. Department of Pathology, St. Vincent’s Hospital, Catholic University, Suwon, South Korea esis of gastric cancer and may reflect, along with Telomerase is an RNA-dependent DNA polymerase enhanced hTR, the malignant potential of the tu- that synthesizes TTAGGG telomeric DNA onto chro- mor. It is noteworthy that methacarn-fixed tissue mosome ends to compensate for sequence loss dur- cannot as yet substitute for the frozen section in the ing DNA replication. It has been detected in 85–90% TRAP assay. of all primary human cancers, implicating that the telomerase seems to be reactivated in tumors and KEY WORDS: hTR, Stomach cancer, Telomerase, that such activity may play a role in the tumorigenic TERT. process. The purpose of this study was to evaluate Mod Pathol 2003;16(7):700–707 telomerase activity, human telomerase RNA (hTR), and telomerase reverse transcriptase (TERT) in Recent studies of stomach cancer have been di- stomach cancer and to determine their potential rected toward gaining a better understanding of relationships to clinicopathologic parameters. Fro- tumor biology. Molecular analysis has suggested zen and corresponding methacarn-fixed paraffin- that alterations in the structures and functions of embedded tissue samples were obtained from 51 oncogenes and tumor suppressor genes, genetic patients with gastric adenocarcinoma and analyzed instability, as well as the acquisition of cell immor- for telomerase activity by using a TRAPeze ELISA tality may be of relevance in the pathogenesis of kit. -
Llll|Llll Technical Tips
Downloaded from genome.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press llll|llll Technical Tips The reverse transcriptase-polymerase reverse transcriptase, the multiple Single-step chain reaction (RT-PCR) provides an ef- rounds of amplification catalyzed by Elimination of fective method for detecting very small DNA polymerase are equally effective amounts of a specific mRNA in a small at amplifying either the cDNA or con- Contaminating sample of total RNA.O,2) Unfortunate- taminating genomic DNA. Even mi- DNA Prior to ly, for purposes of detecting RNA by nuscule amounts of contaminating this procedure, after the initial step of DNA (<1%) can produce a false- Reverse converting RNA into cDNA using positive amplification signal in an RT- Transcriptase PCR Donald D. Dilworth and John R. McCarrey Department of Genetics, Southwest Foundation for Biomedical Research, San Antonio, Texas 78228 FIGURE 1 Effects of pretreatment with nuclease on production of amplification signals by RT-PCR. Five hundred nanograms of total RNA from mouse liver supplemented with 0, 1, 5, or 10% genomic DNA was subjected to RT-PCR using primers determined from the mouse 13- actin cDNA sequence, (14) and reverse transcriptase and AmpliTaq DNA polymerase (Perkin- Elmer Cetus). Primers used were: (upstream) 5'-GCGGACTGTTACTGAGCTGCGT-3' and (downstream) 5 ' -GAAGCAATGCTGTCACCTTCCC-3 ', which delineated a 453-bp amplifica- tion product from either a cDNA or genomic DNA template, since this sequence apparently does not span an intron in genomic DNA. In each case a comparison of amplification with (+) or without (-) the addition of reverse transcriptase is shown. (A) RT-PCR with no prior nuclease treatment. -
Optimization of the TRAP Assay to Evaluate Specificity of Telomerase Inhibitors
Laboratory Investigation (2005) 85, 1565–1569 & 2005 USCAP, Inc All rights reserved 0023-6837/05 $30.00 www.laboratoryinvestigation.org Optimization of the TRAP assay to evaluate specificity of telomerase inhibitors Kamilla Piotrowska1,*, Elke Kleideiter1,*, Thomas E Mu¨ rdter1, Sebastian Taetz2, Christiane Baldes2, Ulrich Schaefer2, Claus-Michael Lehr2 and Ulrich Klotz1 1Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany and 2Department of Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbru¨cken, Germany Telomerase inhibition represents a promising approach to anticancer treatment. In order to clarify the therapeutic potential of telomerase inhibitors we examined different substances (small molecule compounds BIBR1532 and BRACO19, as well as hTR antisense oligonucleotides 20-O-methyl RNA and PNA) in A-549, MCF-7, and Calu-3 cell lines in a cell-free TRAP assay. We demonstrated that each of the tested agents inhibited telomerase in all used cell lines and that the antisense oligonucleotides represent the most potent inhibitors. Interestingly, upon evaluating the specificity of telomerase inhibitors we found out that not all agents acted specifically against telomerase. We observed that BRACO19 and PNA had an inhibitory effect also on PCR s amplification of the TSR8 oligonucleotide which is provided in the TRAPEZE kit as a PCR control. By modifying the experimental protocol and using a different reverse primer we were able to enhance PNA selectivity, although the PCR inhibition of the TSR8 control template by BRACO19 could not be prevented. We propose an explanation for the lack of target specificity and suggest caution when testing putative telomerase inhibitors, as it appears that some of those substances may not affect specifically telomerase or telomeric G-rich sequences and thus can lead to the misinterpretation of experimental results. -
DNA Polymerase V Activity Is Autoregulated by a Novel Intrinsic DNA-Dependent
1 2 DNA polymerase V activity is autoregulated by a novel intrinsic DNA-dependent 3 ATPase 4 Aysen L. Erdem1, Malgorzata Jaszczur1, Jeffrey G. Bertram1, Roger Woodgate2, Michael M. Cox3 & 5 Myron F. Goodman1 6 1Departments of Biological Sciences and Chemistry, University of Southern California, University 7 Park, Los Angeles, California 90089-2910, USA. 2Laboratory of Genomic Integrity, National 8 Institute of Child Health and Human Development, National Institutes of Health, Bethesda, 9 Maryland 20892-3371, USA. 3Department of Biochemistry, University of Wisconsin-Madison, 10 Madison, Wisconsin 53706, USA. 11 12 Escherichia coli DNA polymerase V (pol V), a heterotrimeric complex composed of UmuD′2C, 13 is marginally active. ATP and RecA play essential roles in the activation of pol V for DNA 14 synthesis including translesion synthesis (TLS). We have established three features of the roles 15 of ATP and RecA. 1) RecA-activated DNA polymerase V (pol V Mut), is a DNA-dependent 16 ATPase; 2) bound ATP is required for DNA synthesis; 3) pol V Mut function is regulated by 17 ATP, with ATP required to bind primer/template (p/t) DNA and ATP hydrolysis triggering 18 dissociation from the DNA. Pol V Mut formed with an ATPase-deficient RecA E38K/K72R 19 mutant hydrolyzes ATP rapidly, establishing the DNA-dependent ATPase as an intrinsic 20 property of pol V Mut distinct from the ATP hydrolytic activity of RecA when bound to 21 single-stranded (ss)DNA as a nucleoprotein filament (RecA*). No similar ATPase activity or 22 autoregulatory mechanism has previously been found for a DNA polymerase. -
Datasheet for Longamp® Taq DNA Polymerase (M0323; Lot 0101212)
Unit Definition: One unit is defined as the amount 3. Mg++ and additives: 25 µl 50 µl FInal ® ++ LongAmp Taq of enzyme that will incorporate 10 nmol of dNTP COMPONENT REacTION REacTION CONCENTRATION Mg concentration of 1.5–2.0 mM is optimal into acid insoluble material in 30 minutes at 75°C. 5X LongAmp Taq for most PCR products generated with ++ DNA Polymerase Reaction Buffer 5 µl 10 µl 1X LongAmp Taq DNA Polymerase. The final Mg ™ Unit Assay Conditions: 1X ThermoPol Reaction 10 mM dNTPs 0.75 µl 1.5 µl 300 µM concentration in 1X LongAmp Taq Reaction Buffer, 200 µM dNTPs including [3H]-dTTP and Buffer is 2 mM. This supports satisfactory 1-800-632-7799 10 µM Forward Primer 1 µl 2 µl 0.4 µM (0.05–1 µM) [email protected] 200 µg/ml activated Calf Thymus DNA. amplification of most amplicons. However, www.neb.com 10 µM Reverse Primer 1 µl 2 µl 0.4 µM (0.05–1 µM) Mg++ can be further optimized in 0.5 or 1.0 M0323S 010121214121 Heat Inactivation: No LongAmp Taq 5 units/ mM increments using MgSO . DNA Polymerase 1 µl 2 µl 50 µl PCR 4 Quality Control Assays Amplification of some difficult targets, like M0323S Template DNA variable variable <1,000 ng GC-rich sequences, may be improved Long Amplicon PCR: LongAmp Taq DNA Poly- Nuclease-Free Water to 25 µl to 50 µl 500 units 2,500 U/ml Lot: 0101212 merase is tested for the ability to amplify a 30 kb with additives, such as DMSO (4) or amplicon from lambda DNA and a 30 kb amplicon Notes: Gently mix the reaction. -
For Improvement of Nucleic Acid Synthesis and Ampli
Europäisches Patentamt *EP001088891B1* (19) European Patent Office Office européen des brevets (11) EP 1 088 891 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.7: C12N 15/55, C12N 15/54, of the grant of the patent: C12N 9/22, C12N 9/12, 12.01.2005 Bulletin 2005/02 C12Q 1/68, C12P 19/34 (21) Application number: 99119268.3 (22) Date of filing: 28.09.1999 (54) Thermostable enzyme promoting the fidelity of thermostable DNA polymerases - for improvement of nucleic acid synthesis and amplification in vitro Thermostabiles Enzym welches die Genauigkeit thermostabiler DNA Polymerasen erhöht - zur Verbesserung der Nucleinsäuresynthese und in vitro Amplifikation Enzyme thermostable pour augmenter la fidélité de polymèrase d’ADN thermostable - pour l’amélioration de la synthèse des acides nucléiques et d’amplification in vitro (84) Designated Contracting States: • KLENK H-P ET AL: "The complete genome AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU sequence of the hyperthermophilic, MC NL PT SE sulphate-reducing archaeon Archaeoglobus fulgidus" NATURE,GB,MACMILLAN JOURNALS (43) Date of publication of application: LTD. LONDON, vol. 390, 27 November 1997 04.04.2001 Bulletin 2001/14 (1997-11-27), pages 364-370, XP002091622 ISSN: 0028-0836 (73) Proprietor: Roche Diagnostics GmbH • KALUZ S ET AL: "DIRECTIONAL CLONING OF 68298 Mannheim (DE) PCR PRODUCTS USING EXONUCLEASE III" NUCLEIC ACIDS RESEARCH,GB,OXFORD (72) Inventors: UNIVERSITY PRESS, SURREY, vol. 20, no. 16, 1 • Dr.Waltraud Ankenbauer January 1992 (1992-01-01), pages 4369-4370, 82377 Penzberg (DE) XP002072726 ISSN: 0305-1048 • Franck Laue • BOOTH P M ET AL: "ASSEMBLY AND CLONING 82396 Paehl-Fischen (DE) OF CODING SEQUENCES FOR NEUROTROPHIC • Dr.Harald Sobek FACTORS DIRECTLY FROM GENOMIC DNA 82377 Penzberg (DE) USING POLYMERASE CHAIN REACTION AND • Michael Greif URACIL DNA GLYCOSYLASE" 83661 Lenggries (DE) GENE,NL,ELSEVIER BIOMEDICAL PRESS. -
Human Glucokinase Gene
Proc. Nati. Acad. Sci. USA Vol. 89, pp. 7698-7702, August 1992 Genetics Human glucokinase gene: Isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus (glucose/metabolism/phosphorylation/structure4unctlon/chromosome 7) M. STOFFEL*, PH. FROGUELt, J. TAKEDA*, H. ZOUALItt, N. VIONNET*, S. NISHI*§, I. T. WEBER¶, R. W. HARRISON¶, S. J. PILKISII, S. LESAGEtt, M. VAXILLAIREtt, G. VELHOtt, F. SUNtt, F. lIRSt, PH. PASSAt, D. COHENt, AND G. I. BELL*"** *Howard Hughes Medical Institute, and Departments of Biochemistry and Molecular Biology, and of Medicine, The University of Chicago, 5841 South Maryland Avenue, MC1028, Chicago, IL 60637; §Second Division of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-32, Japan; IDepartment of Pharmacology, Jefferson Cancer Institute, Thomas Jefferson University, Philadelphia, PA 19107; IlDepartment of Physiology and Biophysics, State University of New York, Stony Brook, NY 11794; tCentre d'Etude du Polymorphisme Humain, 27 rue Juliette Dodu, and Service d'Endocrinologie, H6pital Saint-Louis, 75010 Paris, France; and tG6ndthon, 1 rue de l'Internationale, 91000 Evry, France Communicated by Jean Dausset, May 28, 1992 ABSTRACT DNA polymorphisms in the glucokinase gene by maintaining a gradient for glucose transport into these cells have recently been shown to be tightly linked to early-onset thereby regulating hepatic glucose disposal. In (3 cells, glu- non-insulin-dependent diabetes mellitus in "80% of French cokinase is believed to be part of the glucose-sensing mech- families with this form of diabetes. We previously identified a anism and to be involved in the regulation ofinsulin secretion. -
Arthur Kornberg Discovered (The First) DNA Polymerase Four
Arthur Kornberg discovered (the first) DNA polymerase Using an “in vitro” system for DNA polymerase activity: 1. Grow E. coli 2. Break open cells 3. Prepare soluble extract 4. Fractionate extract to resolve different proteins from each other; repeat; repeat 5. Search for DNA polymerase activity using an biochemical assay: incorporate radioactive building blocks into DNA chains Four requirements of DNA-templated (DNA-dependent) DNA polymerases • single-stranded template • deoxyribonucleotides with 5’ triphosphate (dNTPs) • magnesium ions • annealed primer with 3’ OH Synthesis ONLY occurs in the 5’-3’ direction Fig 4-1 E. coli DNA polymerase I 5’-3’ polymerase activity Primer has a 3’-OH Incoming dNTP has a 5’ triphosphate Pyrophosphate (PP) is lost when dNMP adds to the chain E. coli DNA polymerase I: 3 separable enzyme activities in 3 protein domains 5’-3’ polymerase + 3’-5’ exonuclease = Klenow fragment N C 5’-3’ exonuclease Fig 4-3 E. coli DNA polymerase I 3’-5’ exonuclease Opposite polarity compared to polymerase: polymerase activity must stop to allow 3’-5’ exonuclease activity No dNTP can be re-made in reversed 3’-5’ direction: dNMP released by hydrolysis of phosphodiester backboneFig 4-4 Proof-reading (editing) of misincorporated 3’ dNMP by the 3’-5’ exonuclease Fidelity is accuracy of template-cognate dNTP selection. It depends on the polymerase active site structure and the balance of competing polymerase and exonuclease activities. A mismatch disfavors extension and favors the exonuclease.Fig 4-5 Superimposed structure of the Klenow fragment of DNA pol I with two different DNAs “Fingers” “Thumb” “Palm” red/orange helix: 3’ in red is elongating blue/cyan helix: 3’ in blue is getting edited Fig 4-6 E. -
Taming the Wild Rubisco: Explorations in Functional Metagenomics
Taming the Wild RubisCO: Explorations in Functional Metagenomics DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Brian Hurin Witte, M.S. Graduate Program in Microbiology The Ohio State University 2012 Dissertation Committee : F. Robert Tabita, Advisor Joseph Krzycki Birgit E. Alber Paul Fuerst Copyright by Brian Hurin Witte 2012 Abstract Ribulose bisphosphate carboxylase/oxygenase (E.C. 4.1.1.39) (RubisCO) is the most abundant protein on Earth and the mechanism by which the vast majority of carbon enters the planet’s biosphere. Despite decades of study, many significant questions about this enzyme remain unanswered. As anthropogenic CO2 levels continue to rise, understanding this key component of the carbon cycle is crucial to forecasting feedback circuits, as well as to engineering food and fuel crops to produce more biomass with few inputs of increasingly scarce resources. This study demonstrates three means of investigating the natural diversity of RubisCO. Chapter 1 builds on existing DNA sequence-based techniques of gene discovery and shows that RubisCO from uncultured organisms can be used to complement growth in a RubisCO-deletion strain of autotrophic bacteria. In a few short steps, the time-consuming work of bringing an autotrophic organism in to pure culture can be circumvented. Chapter 2 details a means of entirely bypassing the bias inherent in sequence-based gene discovery by using selection of RubisCO genes from a metagenomic library. Chapter 3 provides a more in-depth study of the RubisCO from the methanogenic archaeon Methanococcoides burtonii. -
Processivity of DNA Polymerases: Two Mechanisms, One Goal Zvi Kelman1*, Jerard Hurwitz1 and Mike O’Donnell2
Minireview 121 Processivity of DNA polymerases: two mechanisms, one goal Zvi Kelman1*, Jerard Hurwitz1 and Mike O’Donnell2 Replicative DNA polymerases are highly processive Processive DNA synthesis by cellular replicases and the enzymes that polymerize thousands of nucleotides without bacteriophage T4 replicase dissociating from the DNA template. The recently Until recently, the only mechanism for high processivity determined structure of the Escherichia coli bacteriophage that was understood in detail was that utilized by cellular T7 DNA polymerase suggests a unique mechanism that replicases and the replicase of bacteriophage T4. This underlies processivity, and this mechanism may generalize mechanism involves a ring-shaped protein called a ‘DNA to other replicative polymerases. sliding clamp’ that encircles the DNA and tethers the polymerase catalytic unit to the DNA [3,4]. The three- Addresses: 1Department of Molecular Biology, Memorial Sloan- dimensional structures of several sliding clamps have been Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, 2 determined: the eukaryotic proliferating cell nuclear USA and Laboratory of DNA Replication, Howard Hughes Medical β Institute, The Rockefeller University, 1230 York Avenue, New York, NY antigen (PCNA) [5,6]; the subunit of the prokaryotic 10021, USA. DNA polymerase III [7]; and the bacteriophage T4 gene 45 protein (gp45) (J Kuriyan, personal communication) *Corresponding author. (Figure 1). The overall structure of these clamps is very E-mail: [email protected] similar; the PCNA, β subunit and gp45 rings are super- Structure 15 February 1998, 6:121–125 imposable [8]. Each ring has similar dimensions and a http://biomednet.com/elecref/0969212600600121 central cavity large enough to accommodate duplex DNA (Figure 1). -
Enhancing Terminal Deoxynucleotidyl Transferase Activity on Substrates
G C A T T A C G G C A T genes Communication Enhancing Terminal Deoxynucleotidyl Transferase 0 Activity on Substrates with 3 Terminal Structures for Enzymatic De Novo DNA Synthesis 1,2,3, 1,2,3, 1,2,4 Sebastian Barthel y , Sebastian Palluk y, Nathan J. Hillson , 1,2,5,6,7,8,9 1,2,5,10, , Jay D. Keasling and Daniel H. Arlow * y 1 Joint BioEnergy Institute, Emeryville, CA 94608, USA; [email protected] (S.B.); [email protected] (S.P.); [email protected] (N.J.H.); [email protected] (J.D.K.) 2 Biological Systems and Engineering Division, Lawrence Berkeley National Lab, Berkeley, CA 94720, USA 3 Department of Biology, Technische Universität Darmstadt, 64287 Darmstadt, Germany 4 DOE Joint Genome Institute, Walnut Creek, CA 94598, USA 5 Institute for Quantitative Biosciences, UC Berkeley, Berkeley, CA 94720, USA 6 Department of Chemical and Biomolecular Engineering, UC Berkeley, Berkeley, CA 94720, USA 7 Department of Bioengineering UC Berkeley, Berkeley, CA 94720, USA 8 Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2970 Hørsholm, Denmark 9 Center for Synthetic Biochemistry, Institute for Synthetic Biology, Shenzhen Institutes for Advanced Technologies, Shenzhen 518055, China 10 Biophysics Graduate Group, UC Berkeley, Berkeley, CA 94720, USA * Correspondence: [email protected]; Tel.: +1-248-227-5556 Current address: Ansa Biotechnologies, Berkeley, CA 94170, USA. y Received: 8 December 2019; Accepted: 7 January 2020; Published: 16 January 2020 Abstract: Enzymatic oligonucleotide synthesis methods based on the template-independent polymerase terminal deoxynucleotidyl transferase (TdT) promise to enable the de novo synthesis of long oligonucleotides under mild, aqueous conditions.